Predictive Biotech Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:2015
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Predictive Biotech's estimated annual revenue is currently $10.2M per year.
  • Predictive Biotech's estimated revenue per employee is $155,000

Employee Data

  • Predictive Biotech has 66 Employees.
  • Predictive Biotech grew their employee count by 27% last year.
  • Predictive Biotech currently has 1 job openings.

Executive Contacts

NameTitle
Jennifer KohorstRegional Vice President of Sales - Midwest
Mike UnderhillVP of Sales - West Region
Simon BrewerChief Financial Officer (cfo)
Steve NettleRegional Vice President of Sales
Michael HerbertEVP - Predictive Technology Group, Chief Sales and Marketing Officer - Predictive Biotech
Julie ColbertVP Sales
Aley DemarestRegional Vice President of Sales
Angela StephensDirector Of Quality Assurance
Jenica FloydHuman Resource Manager
Kim StaplesRegional Vice President: Southwest

Predictive Biotech, Inc., a Salt Lake City, UT life sciences Company formed in 2015, is a leader in human cell and tissue products for use in regenerative medicine. A growing national network of clinics, health systems, researchers and physicians leverage Predictive's four main placental-derived and Wharton's Jelly umbilical cord-derived products. Predictive Biotech products are regulated by the FDA under 21 CFR part 1271 section 361 as minimally manipulated allografts intended for homologous use. Predictive Technology Group, Inc., a Salt Lake City, UT therapeutics and life sciences company, is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. Through its' wholly owned subsidiaries, Predictive Therapeutics, and Predictive Biotech, the company focuses on four main clinical categories: Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. In addition to Predictive Biotech's efforts to advance regenerative medicine, Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment.

keywords:N/A

66

Number of Employees

$10.2M

Revenue (est)

1

Current Jobs

27%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
PolarityTE
$1.6M121-21%N/A
Predictive Biot...
$10.2M6627%N/A
ZYTO
$8.7M568%N/A
Scientific Comp...
$6.4M41-20%N/A
Carterra
$9.9M6421%N/A

Predictive Biotech News

09/03/2019 - Predictive Technology Group Names Biologic Industry Leader ...

Predictive Technology Group Names Biologic Industry Leader Jeff Acuff As Chief Commercial Officer Of Predictive Biotech ...

05/14/2019 - Predictive Biotech Signs Letter of Intent With IQVIA to Begin Clincial Trial for Osteoarthritis of the Knee

Specifically, IQVIA will guide Predictive Biotech in its U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) application and ...

09/03/2019 - Predictive Technology Group Accelerates Research Sample Collections to Support Development of Personalized Molecular Diagnostics and Clinical Therapies

Subsidiary Predictive Laboratories hits milestone with 2,500 ... through its subsidiaries Predictive Therapeutics, Predictive Biotech, and ...

Predictive Biotech Executive Hires

DateNameTitleReference
2018-10-31John SorrentinoChairmanArticle